RV wanted to focus on USA and you were happy with thatIn fact the CR was to accelerate sales in the USA only, but what has really occurred is ROW is outperforming in sales. That is the past.
Now to the future.
One of the BOD objectives is to get cash flow positive to finance their own growth. Hopefully the existing model will get us there and with positive policy change this can be achieved rather than without policy as was the case over the last 8 years. It only requires 300 more (800 total @ $2500) USA units to get 30M AUD. The existing 500 will be 20M AUD when they get to $2500.
The hurdle is not that high.
Kind regards
Acclivity
Ann: New Clinical Practice Guidance Recommends Use of BIS, page-32
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.9¢ |
Change
0.001(1.28%) |
Mkt cap ! $159.8M | |||
| Open | High | Low | Value | Volume |
| 7.9¢ | 7.9¢ | 7.7¢ | $76.67K | 981.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 290707 | 7.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 121040 | 1 |
View Market Depth
| Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.9¢ |
Change
0.001 ( 2.60 %) |
||||
| Open | High | Low | Volume | ||
| 7.8¢ | 8.0¢ | 7.8¢ | 270459 | ||
| Last updated 15.59pm 29/05/2024 ? | |||||
| IPD (ASX) Chart |